Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.5 (
RNase P
)
1,348
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
M1 RNA of 377 nucleotides, the catalytic subunit of Escherichia coli
RNase P
, is produced by a 3' processing reaction from precursor M1 RNA, a major transcript from the rnpB gene. We analyzed products and intermediates generated by the in vitro processing reaction using a 40% ammonium sulfate precipitate of the S30 fraction (
ASP
-40) and determined their involvement in the processing. From the results we proposed a model of two pathways for 3' processing of M1 RNA. In this model, one pathway (pathway I) involves +385/+386 intermediates and the other pathway (pathway II) does not. The position of the 3'-end of the precursor molecule determined the choice of the pathways. The precursor having the 3'-end of +413 was processed by both pathways while that having the +415 end was processed only by pathway II. The
ASP
-40 fraction generated processing products (termed +378/+379 RNA) containing one or two more nucleotides at the 3'-end than M1 RNA, regardless of which pathway was used. Therefore, both pathways require the final 3' trimming for complete processing. The endonucleolytic generation of +378/+379 RNA by pathway II was blocked by the rne-3071 mutation, suggesting that this step is carried out by RNase E.
...
PMID:In vitro analysis of processing at the 3'-end of precursors of M1 RNA, the catalytic subunit of Escherichia coli RNase P: multiple pathways and steps for the processing. 988 89
M1 RNA, the catalytic component of Escherichia coli
RNase P
, is derived from the 3'-end processing of precursor M1 RNA, a major transcript of the rnpB gene. In this study, we investigated the mechanism of 3'-end processing of M1 RNA using the recombinant N-terminal half RNase E. The cleavage site preference of RNase E differed from that of the 40% ammonium sulfate precipitate (
ASP
-40), a partially purified cell extract containing processing activity. However, the addition of a trace amount of
ASP
-40 changed the cleavage site preference of RNase E to that of
ASP
-40 suggesting the involvement of a soluble factor in cleavage site preference.
...
PMID:3'-end processing of precursor M1 RNA by the N-terminal half of RNase E. 1237 5